{"prompt": "['Tofacitinib', 'A3921284 NON-INTERVENTIONAL STUDY PROTOCOL', 'Amended, 12-December-2018', '3.', 'INVESTIGATOR SIGNATURE', 'I have read and approve this protocol. My signature, in conjunction with the signature of', 'the sponsor, confirms the agreement of both parties that the clinical study will be conducted', 'in accordance with the protocol and all applicable laws and regulations including, but not', 'limited to, the International Conference on Harmonisation (ICH) Guideline for Good', 'Clinical Practice (GCP), the ethical principles that have their origins in the Declaration of', 'Helsinki, and applicable privacy laws.', 'Nothing in this document is intended to limit the authority of a physician to provide', 'emergency medical care under applicable regulations.', 'Investigator', 'Date of signature', 'Time', 'Signature', '(DD Mmm YYYY)', '(Time zone)', 'Investigator Name and Title', 'CONFIDENTIAL', 'Page 7 of 64']['Tofacitinib', 'A3921284 NON-INTERVENTIONAL STUDY PROTOCOL', 'Amended, 12-December-2018', '4. LIST OF ABBREVIATIONS', 'Abbreviation', 'Definition', 'ACR', 'American College of Rheumatology', 'AE', 'Adverse Event', 'AEM', 'Adverse Event Monitoring', 'ARCSA', '\"Agencia Nacional de Regulaci\u00f3n Controly', 'Vigilancia Sanitaria\"', 'CRA', 'Clinical Research Associate', 'CRF', 'Case Report Form', 'CRO', 'Clinical Research Organization', 'CTCAE', 'Common Terminology Criteria for Adverse Events', 'DAS28', 'Disease Activity Score 28', 'DGDF', '\"Direcci\u00f3n General de Drogas Farmacias\"', 'DIGEMID', '\"Direcci\u00f3n General de Medicamentos e Insumos y', 'Drogas\"', 'DMARDs', 'Disease-modifying Antirheumatic Drugs', 'EBV', 'Epstein Barr Virus', 'EDP', 'ESR', 'ON', 'Exposure During Pregnancy', 'Erythrocyte sedimentation rate', 'EULAR', 'European League Against Rheumatism', 'FN', 'Physical function', 'GH', 'General Health', 'HAQ-DI', 'Health Assessment Questionnaire - Disability Index', 'ICH', 'International Conference on Harmonization', 'IEC', 'Independent Ethics Committee', 'INVIMA', '\"Instituto Nacional de Vigilancia de Medicamentos', 'V Alimentos\"', 'IRB', 'Institutional Review Board', 'ISP', '\"Instituto de Salud P\u00fablica\"', 'JAK', 'Janus Kinase', 'LSLV', 'Last Subject Last Visit', 'MDHAQ', 'Multidimensional Health Assessment Questionnaire', 'MTX', 'Methotrexate', 'NI', 'Non-Interventional', 'NIS', 'Non-Interventional Study', 'PN', 'Pain', 'PRO', 'Patient Reported Outcome', 'Page 8 of 64']['Tofacitinib', 'A3921284 NON-INTERVENTIONAL STUDY PROTOCOL', 'Amended, 12-December-2018', 'PTGL', 'Patient global', 'RA', 'Rheumatoid Arthritis', 'RAPID', 'Routine Assessment of Patients Index Data', 'SAE', 'Serious Adverse Event', 'SHP', 'specific health problem', 'SRSD', 'Single reference safety document', 'TNF', 'Tumor Necrosis Factor', 'WPAI', 'Work Productivity and Activity Impairment', 'CONFIDENTIAL', 'Page 9 of 64']\n\n###\n\n", "completion": "END"}